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AbstrACt
background The use of advance care planning and 
advance decisions for psychiatric care is growing. 
However, there is limited guidance on clinical management 
when a patient presents with suicidal behaviour and an 
advance decision and no systematic reviews of the extant 
literature.
Objectives To synthesise existing literature on the 
management of advance decisions and suicidal behaviour.
Design A systematic search of seven bibliographic 
databases was conducted to identify studies relating to 
advance decisions and suicidal behaviour. Studies on 
terminal illness or end-of-life care were excluded to focus 
on the use of advance decisions in the context of suicidal 
behaviour. A textual synthesis of data was conducted, 
and themes were identified by using an adapted thematic 
framework analysis approach.
results Overall 634 articles were identified, of which 
35 were retained for full text screening. Fifteen relevant 
articles were identified following screening. Those articles 
pertained to actual clinical cases or fictional scenarios. 
Clinical practice and rationale for management decisions 
varied. Five themes were identified: (1) tension between 
patient autonomy and protecting a vulnerable person, 
(2) appropriateness of advance decisions for suicidal 
behaviour, (3) uncertainty about the application of 
legislation, (4) the length of time needed to consider all the 
evidence versus rapid decision-making for treatment and 
(5) importance of seeking support and sharing decision-
making.
Conclusions Advance decisions present particular 
challenges for clinicians when associated with suicidal 
behaviour. Recommendations for practice and supervision 
for clinicians may help to reduce the variation in clinical 
practice.
IntrODuCtIOn  
An advance decision (sometimes known as 
an advance decision to refuse treatment or 
living will) is typically a written document that 
outlines a person’s desire to refuse certain 
treatments, including life-saving treatment, 
when there is a potential for a person to lose 
the mental capacity to make treatment deci-
sions in the future.1 In order for an advance 
decision to be valid, the person must have 
mental capacity at the time of writing the 
document. Mental capacity is defined as the 
ability to make a decision and involves under-
standing and weighing information relating 
to a decision and alternative options and 
retaining that information long enough to 
make the decision.1 The Mental Capacity Act 
in England and Wales refers to ‘advance deci-
sions to refuse treatment’, but more widely 
these documents are referred to as ‘advance 
directives’ and/or ‘living wills’. We use 
‘advance decision’ throughout in this paper 
to refer to written documents stating a refusal 
of treatment made in advance of medical 
treatment following an illness or injury.
There are important cross-national vari-
ations in legislation; in some countries, the 
use of advance decisions is not permitted (ie, 
Turkey, Japan), while in others, advance deci-
sions are legislated for (ie, the UK and USA). 
The UK, Australia and USA have similar 
legal standards with some state-wide variation 
in the USA and Australia,2 with some states 
adopting the common law right to make an 
advance decision and others allowing the use 
of a surrogate or proxy decision-maker (ie, to 
make healthcare decisions on behalf of the 
patient). There is also considerable variation 
in practice between countries where advance 
decisions are permitted. For example, in 
strengths and limitations of this study
 ► Timely systematic review considering the challeng-
es relating to advance decisions in the context of 
suicidal behaviour.
 ► Review involves journal articles from a variety of 
countries from a range of disciplines.
 ► Paucity of evidence for this specific presentation of 
advance decision.
 ► Evidence in this area is predominately from reviews 
of case studies, rather than empirical work.
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Germany, advance decisions are recognised but require 
court approval in each case.2
Advance care planning for psychiatric care is becoming 
more common in a number of countries, including the 
UK, USA and Australia3 4 and enables patients to state 
their preferences for the management of their mental 
health when they may temporarily lose their mental 
capacity. A person with a mental health disorder may 
also make some decisions about particular treatment that 
they would not wish to have and may involve an advance 
decision to refuse particular treatments (ie, electrocon-
vulsive therapy). Advance care planning has been shown 
to have a number of healthcare benefits for mental health 
patients in the UK and USA, such as enhancing patient 
autonomy and engagement, promoting adherence to 
treatment plans (ie, patients taking prescribed drugs), 
improving continuity of care with fewer psychiatric admis-
sions, reducing the use of social workers’ time and lower 
levels of violent acts.3 4 In a recent survey of patients with 
bipolar disorder, 21% had written statements about their 
healthcare, and of those, 10% involved an advance deci-
sion.5 This increasing use of advance care planning in 
mental health may result in an increasing use of advance 
decisions to refuse mental healthcare treatment, and 
concerns about clinical management of advance decisions 
following suicidal behaviour have been made by health-
care professionals and legal and ethical consultants.6–8 
Existing literature, from a variety of academic and clinical 
perspectives, suggests there is little consistency in prac-
tice, and there are specific challenges with advance deci-
sions following suicidal behaviour. Such scenarios raise 
questions about whether a person with a wish to end their 
life has the capacity to make a decision about refusal of 
treatment and/or if their capacity is affected by mental 
illness, and whether an advance decision is appropriate 
for medical treatment following suicidal behaviour.8
The terminology for suicidal behaviour varies interna-
tionally. Some clinicians/researchers distinguish between 
suicide attempts and non-suicidal self-injury,9 while others 
prefer the broad term of self-harm to denote behaviours 
across the spectrum.1 10 We have taken an inclusive 
approach in this review to ensure we captured relevant 
studies, so in this review we refer to ‘suicidal behaviour’ 
as behaviours including all self-harming behaviour 
(including non-suicidal injury) and suicide attempts. The 
use of ‘suicidal behaviour’ in our review means that there 
may be cases of non-suicidal injury that were included.
The management of suicidal behaviour is a signifi-
cant challenge for clinicians in the emergency services. 
Each year over 200 000 people present to emergency 
departments (EDs) in England with self-harm,10 with 
16% of those presenting to hospital with a repeat self-
harm episode within a year.11 Treatment refusal following 
suicidal behaviour has been shown to be common. A 
prospective cohort study of mental capacity and suicidal 
behaviour in the ED found that around 40% of patients 
presenting to hospital with self-harm had the capacity to 
make a decision about their medical treatment and 30% 
of those intended to refuse life-saving treatment.12 There 
are few studies that have examined numbers of advance 
decisions to refuse treatment in patients presenting with 
suicidal behaviour, but in a recent study in three of 121 
fatal cases of self-poisoning in 2005, patients had an 
advance decision.13 Given that patient autonomy and 
advance care planning are encouraged in modern health-
care and are assuming greater prominence, it is likely 
that the number of people presenting to hospital with an 
advance decision following suicidal behaviour will grow.
rationale
While reviews of literature relating to the management of 
advance decisions, both more broadly and specifically to 
relating to ‘end-of-life’ care exist,14 15 there are currently 
no reviews on the management of advance decisions when 
a patient presents to hospital following suicidal behaviour 
where the patient does not have a chronic or terminal 
physical illness. Despite the legislative context being 
similar for end-of-life care, the ethical considerations, 
emotional challenges and clinical decision-making may 
be different for treatment of a patient following suicidal 
behaviour without a chronic or terminal physical illness. 
A synthesis of this literature is important to examine 
similarities and differences and to establish the key find-
ings. This is particularly important as the management 
of advance decisions to refuse treatment of injuries and 
illnesses following suicidal behaviour is challenging for 
clinicians8 and there is a lack of consistency of practice. A 
review of the literature will be important to inform guide-
lines for the management of advance decisions following 
suicidal behaviour.
Aim
To systematically review and synthesise literature on 
the treatment and clinical management of patients 
presenting to hospital with an advance decision to refuse 
treatment following suicidal behaviour without a chronic 
or terminal physical illness. The review was conducted 
by researchers in the UK, but an examination of all the 
existing literature was conducted without language or 
country restrictions.
MethOD
The review was conducted in accordance with Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) guidelines16 17 and guidance for conducting 
narrative synthesis in healthcare.18 There is no protocol 
for the review. We used the PRISMA checklist when 
writing our report.16
search strategy and data sources
An initial scoping of the literature was conducted at incep-
tion of the study and the findings were used to inform 
the search strategy. Content experts and clinical prac-
titioners on the research team assisted with compiling 
keywords and/or phrases (see table 1). In order to take 
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an inclusive approach and enable inclusion of any papers 
that involved discussion of management of advance deci-
sions following ‘suicidal behaviour’ we included a variety 
of key search terms relating to non-accidental injury and 
suicide attempts. An electronic search of six databases 
(EMBASE, MEDLINE, PSYCHINFO, Social Policy and 
Practice, CINAHL and Medline) was conducted, as well as 
a full electronic search on WestLaw (an online library of 
UK legal information) using the following search terms: 
advance decisions, advance directives AND wills, suicide. Full 
search strategy for each database is supplied as supple-
mentary information (online supplementary information 
1). In addition, the reference sections of all included 
sources were consulted and authors’ personal files were 
also searched to ensure that potentially eligible sources 
were not omitted. No study design, date or language 
restrictions were imposed.
Literature searches were conducted during the period 
April 2016–July 2018. The specific inclusion and exclu-
sion criteria are detailed in table 2.
study selection
Titles and abstracts were screened, with a random sample 
of 10% of the articles independently screened by another 
researcher. Additional information was sought where 
there were any disagreements, which were then resolved 
through discussion. An acceptable concordance rate 
between the inclusion decisions was predefined as agree-
ment on at least 90% of the articles, which was achieved 
for screening on title and abstract. Full text screening of 
the selected articles was conducted by two researchers 
independently, with full agreement being achieved at this 
stage.
Table 1 Search terms for each topic
Advance directives OR Mental capacity AND Suicidal behaviour
advance decisions
advance directives
advance statement
living will(s)
mental health directive
Ulysses contract(s)
psychiatric will(s)
antecedent decision/wish
pre-emptive suicide
antecedent refusal
resuscitation order
health care power of attorney
mental competency
mental capacity
suicide
attempted suicide
self-mutilation
self-harm
deliberate self-harm
parasuicide
self-injurious behaviour
drug overdose
self-immolation
self-poisoning
self-destructive behaviour
auto aggression
automutilation
Table 2 Criteria for inclusion and exclusion
Parameter Inclusion criteria Exclusion criteria
Patients Patients over 18 years who present to hospital with advance 
decisions* (also include do not resuscitate orders, DNRs) 
following suicidal behaviour (including attempted suicide, 
deliberate self-harm, self-injurious behaviour, drug overdose, 
self-poisoning, self-destructive behaviour) with no existing 
chronic or terminal physical conditions.
Patients who present to hospital with 
advance decisions but with primary 
conditions which were not mental 
health related (eg, HIV/AIDS, chronic 
physical health conditions or disabilities, 
neurodegenerative diseases and/or specific 
patient groups (eg, mother/baby)).
Intervention Medical management and/or medicolegal and/or ethical 
consultation/discussion.
Medical management of euthanasia, 
assisted suicide, end of life, wills/
inheritance (ie, monetary or property 
issues).
Comparator
Outcomes Adherence/non-adherence with advance decision, treatment, 
patient outcome (ie, death).
Study design Opinion and review articles, case studies, empirical studies/
surveys.
Book reviews, responses to articles, 
conference abstracts.
*Or other terms such as advance decisions, advance directives, advance statement, living will(s), mental health directive, Ulysses contract(s), 
psychiatric will(s), mental competency, mental capacity, healthcare power of attorney, antecedent decision/wish, pre-emptive suicide, 
antecedent refusal, resuscitation order or living will, advance directive, Ulysses contract.
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Data extraction and analysis
A preliminary analysis of the data was conducted.18 
Studies were from a range of disciplines (ie, general 
medical, psychiatry, ethical, legal) and involved reviews 
of clinical cases or fictional scenarios. It was deemed 
appropriate to conduct a narrative synthesis because this 
particular approach is useful when synthesising textual 
findings from diverse literatures.18 Narrative synthesis was 
conducted in two phases: (1) a textual synthesis and (2) an 
adapted thematic framework analysis.19
First, the textual synthesis of the data was conducted 
by extracting key factual information from each study 
(country of origin, perspective/discipline, factual or 
fictional case study) and details of the case studies (age 
of patient, mental health disorders, nature of suicidal 
behaviour, resulting injuries/illness, hospital admit-
tance, type of advance decision, when the advance deci-
sion was written, and whether patient was conscious, 
decision-making processes). The information was then 
summarised and tabulated to map the literature that 
cited the same clinical case. Information from cases only 
involving a factual case study (ie, a real clinical case) 
was extracted because we were interested in informa-
tion about actual clinical cases, decision-making process 
and rationale for decisions made. Thus, information was 
not extracted from reports that discussed a hypothetical 
scenario for the textual synthesis. Data extraction and 
summarisation was completed independently by two 
researchers using a predetermined data extraction sheet.
Second, an adapted thematic framework analysis 
approach19 was used to examine key themes discussed 
in the selected papers. This involved five stages: initial 
open coding, indexing, descriptive summaries, charting 
and tabulation and interpretation. Initial open coding 
generated three general categories representing the 
most discussed issues across the selected articles: (1) 
key issues with an advance decision relating to suicidal 
behaviour, (2) challenges in clinical decision-making 
for advance decisions relating to suicidal behaviour and 
(3) recommendations for practice. These three catego-
ries were used to index the data and as a framework to 
extract and summarise data. Extracted data were then 
used to form descriptive summaries. Indexing, extracting 
and summarising were conducted independently by two 
researchers. Resulting summaries were compared and 
discussions were held to clarify any differences. Charting 
and tabulation was conducted by charting the summaries by 
discipline. In order to explore similarities and differences 
between disciplines, we distinguished between ‘General 
Medical’ as papers written from a general medical prac-
tice or emergency services perspective; ‘Psychiatry’ as 
those written by clinical psychiatrists or from a psychi-
atry perspective, ‘Nursing’ as those written by practising 
nurses or research nurses, ‘Bioethics’ as those in ethics 
sections in journals or written by researchers in medical 
ethics, ‘Ethics’ as those in ethics journals or written by 
ethics researchers and ‘Legal’ as those written from a legal 
perspective and/or by a legal representative. Interpretation 
of the data was conducted by thematic analysis of the 
summary charts to highlight the main recurrent and 
most important themes.18 Two researchers conducted 
the thematic analysis independently and then discussed 
and finalised themes. Saturation of the themes was estab-
lished when no further themes emerged and could not 
be further collapsed. ‘Vote counting’ was used to iden-
tify the frequency with which the themes appeared in the 
selected papers.20 In the thematic framework analysis all 
selected studies were included; those involving a factual 
case and those involving a fictional case, because both 
involved discussions of concerns, challenges and ratio-
nale for decision-making relating to management of an 
advance decision following suicidal behaviour.
Quality assessment
The papers mostly comprised accounts of clinical cases 
written by clinicians and ethical or legal experts. The 
methodology quality and synthesis of case series and case 
reports tool suggested by Murad and colleagues21 was 
used to assess the quality of selected studies. Each study 
was assessed independently across four areas of potential 
bias: selection, ascertainment, causality and reporting. 
The tool consisted of five items each requiring a binary 
response to indicate whether the bias was likely. We 
considered the quality of the study good when all five 
criteria were fulfilled, moderate when four were fulfilled 
and poor when three or fewer were fulfilled. The meth-
odological quality of included studies was assessed inde-
pendently by two reviewers and discussions were held 
between them where there was disagreement. We also 
considered the reflexivity of the author/s, their exper-
tise and how they were involved in the clinical case (eg, 
as a clinician or legal/ethics consultant). Authors of the 
papers reflected on the management of the clinical case, 
rationale for decision made and issues relating to advance 
decisions and suicidal behaviour more generally.
Patient and public involvement
An expert-by-experience was a co-applicant on the 
National Institute of Health Research (NIHR) Programme 
Grant and actively contributed to the study design and 
objectives. Patient advisors, carers and clinicians evalu-
ated the relevance and importance of the research ques-
tions for the advance decisions component of the grant 
and the systematic review. Our interim and final results 
were presented and evaluated by clinicians, academics, 
patients and carers. There was also patient input into our 
dissemination plan which includes dissemination to clini-
cians and the relevant patient community.
results
systematic search
Results of the systematic search are displayed in figure 1. 
After duplicates were removed, the search returned 634 
articles, of which 35 were retained after screening based 
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on title/abstract. Following full-text screening, 15 articles 
were retained for data extraction.
study characteristics
Descriptive information about the selected articles is 
displayed in table 3. Five of the selected articles were 
from the UK and the others were from the USA (n=7) or 
Australia (n=3). A total of six clinical cases were reviewed 
across the 15 articles (see table 3), as seven (47%) of the 
articles reported the same case (case A, a well-publicised 
case of a 26-year-old woman who died in the UK). Two of 
the clinical cases presented fictional scenarios.2 22
study quality assessment
All 15 studies were assessed for bias using the method-
ology quality and synthesis of case series and case reports 
tool suggested by Murad and colleagues.21 Nine of the 
selected studies were deemed to have moderate method-
ological quality and six to have poor quality (see online 
supplementary information 2). The quality assessment is 
supplied as supplementary information (online supple-
mentary information 2). None of the studies reported 
the representativeness or selection process relating to the 
case report, which impacted on the bias ratings. Although 
case reports are considered to have increased risk of bias, 
they have profoundly influenced medical literature and 
advanced knowledge and their use in reviews is consid-
ered appropriate where no other higher level evidence is 
available.21
textual synthesis
Examination of clinical cases discussed in the selected articles
Specific information about clinical cases and deci-
sion-making is summarised and charted in table 4. We 
only included examination of the factual cases (n=6) in 
this part of the analysis, because we were interested in the 
types of real-world cases and decisions made, rather than 
an examination of a hypothetical scenario.
Patients discussed in the clinical cases varied in age, 
ranging from 26 to 86 years old. All patients were noted 
as having a diagnosis of depression, some were reported 
as also having diagnoses of post-traumatic stress disorder 
and personality disorders. The suicide methods used in 
the cases included self-poisoning (n=3), gunshot inci-
dents (n=2) and hanging (n=1). All patients were found 
by other people, except one patient who called an ambu-
lance because they did not want to die alone. Four of the 
Figure 1 Flow chart of results from initial search. AD, advance decision.
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patients were reported to have died; the outcome in one 
case was not specified.
Treatment was provided in only one of the clinical 
scenarios.23 In this case, the patient was a psychiatric inpa-
tient and the advance decision was considered part of the 
suicide attempt, so the patient’s treatment refusal speci-
fied in the advance decision document was not adhered 
to.
The rationale for non-treatment in the clinical cases 
where the patient died varied and was summarised into 
the following three reasons:
 ► Advance decision was followed as a legally-binding 
document after checks showed the information was 
clear and specific, patient was informed of treatment 
options, had mental capacity at the time of writing 
and family were in agreement with the decision for 
non-treatment (n=1).8 24
 ► Physical injuries were severe resulting in poor prog-
nosis for the patient and the treatment refusal in the 
advance decision was used as evidence that the patient 
would not wish to survive with a life-threatening or 
severely disabling condition. Where possible, families 
were also consulted (n=2).7 25
 ► Verbal treatment refusal was used as the basis for the 
treatment decision, rather than the advance decision, 
because the patient was conscious and had mental 
capacity. Consultation with family was not reported in 
this case. (n=1).6 26–31
The decision-making process was reported to take 
considerable time and legal and/or ethical consultation 
took place in all the reported clinical cases.
Differences in opinions about clinical management 
and decision-making between ED clinicians and psychi-
atric consultants were reported in some of the clinical 
cases.23 25 In those cases, ED clinicians gave more weight 
to the advance decision, suggesting it should be adhered 
to as a legally binding document and the patient remain 
untreated. In contrast psychiatrists viewed suicide as a 
consequence of a distressed state and expressed a pref-
erence to avoid adherence with the advance decision 
and treat the patient. Where such conflict arose this was 
resolved through consultation with the hospital legal 
team and/or ethics committee.
thematic analysis
Five themes arose from the thematic analysis and are 
presented with their corresponding subthemes and vote-
counts in table 5. We included accounts of fictional cases 
in the thematic analysis because here we were interested 
in opinions, views and perspectives of authors.
themes
Tension between patient autonomy and protecting a vulnerable 
person
Professional dilemma: promoting patient autonomy versus 
providing appropriate care
The management of an advance decision in the context of 
suicidal behaviour was particularly challenging because it 
went against healthcare professionals’ training to preserve 
life (ie, adherence to the advance decision could result in 
the death of the patient while they could recover if they 
received treatment for their physical condition). This 
Table 3 Description of selected studies
Author Date Country Perspective*
Fictional/factual 
case Case reported†
Bryne2 2002 Australia Nursing Fictional –
Callaghan and Ryan26 2011 Australia Bioethics Factual A
Chalfin et al25 2001 USA, Philadelphia, 
New York, New 
Zealand
Emergency and acute 
medicine/bioethics
Factual B
Cook et al23 2010 USA, Illinois Psychiatry Factual C
Dresser6 2010 USA, New York Legal Factual A
David et al27 2010 UK Psychiatry Factual A
Frank7 2013 USA, Colorado Legal Factual D
Kapur et al8 2010 UK Psychiatry Factual E
Mitchell22 2011 USA, San Diego Ethical Fictional –
Muzaffer28 2011 UK Psychiatry Factual A
Richardson29 2013 UK Legal Factual A
Ryan and Callaghan30 2010 Australia Psychiatry Factual A
Sontheimer24 2008 USA, Springfield Bioethics Factual E
Szawarski31 2013 UK Bioethics Factual A
Volpe et al32 2012 USA, New York Bioethics Factual F
*Where the perspective is not clearly stated, this has been derived from the author(s) background and professional experience.
†For specific details about each case, see table 4. Note: fictional cases have not been given a case report ID.
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presented clinicians with a dilemma between promoting 
patients’ autonomy by observing their wishes stated in the 
advance decision and by providing care that was consid-
ered in their best interests (eg, promoting life).7 23 26 28 30
Societal expectation to protect vulnerable person and prevent 
suicide
Authors also raised the issue that clinicians not only had 
a professional interest in protecting a vulnerable person, 
but there was also a societal expectation that suicide 
should be prevented.23 25 30 
While the right to autonomy is strong, in some cir-
cumstances there may be competing rights and in-
terests that are sufficient to override a competent 
decision to refuse treatment. These may include the 
state’s interests in preventing suicide.30
The challenge to clinicians was highlighted by an 
acknowledgement from some authors that adherence 
to the advance decision in this context was emotive and 
would feel like assisting suicide.24 30
Appropriateness of advance decisions for suicidal behaviour
Mental health symptoms and suicidal ideation fluctuate
Concerns were expressed about whether an advance deci-
sion should apply in the context of suicidal behaviour 
because of the patients’ distressed state, the potential for 
suicidal ideation to fluctuate and for treatment prefer-
ences to change in the future.7 8 31 32
The compelling notion that people will change their 
minds contradicts the primacy of patient autonomy 
in the consideration of suicide. This is what distin-
guishes an impulsive suicide attempt from other in-
formed choices to obtain or refuse medical treatment 
by patients.7
Authors from a psychiatric perspective, in particular, 
viewed suicidal behaviour as a symptom of a mental health 
disorder that was potentially treatable with psychiatric 
care.25 They also expressed concerns about the capacity 
of a distressed suicidal person to fully comprehend their 
decision and consider all treatment options available to 
them.2 24 25 32 Therefore, it was suggested by some authors 
that a higher level of mental capacity may be required 
at the time of writing the advance decision for clinicians 
to be confident in following it.8 However, other authors 
argued that the advance decision should be considered as 
part of the suicide attempt and as evidence of distressed/
disordered thinking,8 23 27 28 rather than independently 
of the attempt and the treatment refusal in the advance 
decision document should not be adhered to.
Advance decisions for mental and physical health conditions—are 
they the same?
The difference between an advance decision for suicidal 
behaviour and for a physical condition was high-
lighted across the selected papers.6 32 Authors from a 
legal perspective highlighted that the primary aim of 
an advance decision relating to a suicide attempt is to 
end life, whereas an advance decision for a chronic or 
terminal illness is often concerned with managing pain 
and avoiding prolonged suffering.6
There was also debate about the extent to which mental 
suffering legitimised suicide.32 Authors from an ethical 
perspective argued that, typically, healthcare services may 
be more sympathetic to ‘end-of-life’ decisions relating to 
terminal physical health conditions than mental health 
conditions, thus mental health patients do not receive the 
same palliative care options as patients without mental 
health diagnoses.24 There was some discussion that it 
should not be assumed that psychiatric pain is more toler-
able than physical pain and that both should be consid-
ered as having a similar influence on the patient.24 25
Uncertainty about the application of legislation
Confusion and anxiety about litigation
Authors from general medical and psychiatry perspectives 
expressed confusion about legislation and anxiety about 
litigation,2 23 30 with one stating that the advance decision 
document needed to be ‘watertight’ to be considered.25 
Authors recommended that clear hospital policies be 
developed for advance decisions in this particular context 
to overcome the confusion and anxiety about ligation.23
In addition to the clinical demands associated with 
treating a patient with a life-threatening condition, 
clinicians must do their best to ascertain the patient’s 
capacity for his or her apparent decision, consider 
the correct ethical course, and navigate through un-
charted legal waters.7
Authors from the UK and Australia highlighted the diffi-
culties in implementing both mental health and mental 
capacity legislation when managing advance decisions 
relating to suicidal behaviour.27 29–31 Clinicians needed to 
consider whether someone who had attempted suicide 
was suffering with a mental health condition, for which 
they should be treated against their will. They also needed 
to judge whether the person had the capacity to make a 
decision about their treatment and, if so, that the advance 
decision could apply following verification checks. Some 
suggested that application of each legislation model (ie, 
mental health or mental capacity), in isolation of the 
other, could result in different outcomes for the patient.6 
Some authors suggested that the difficulty with balancing 
mental capacity legislation and mental health legislation 
could be resolved by developing a single legislation that 
combines both.8 27
Advance decisions are about more than a simple assessment of 
capacity
A reliance on judging a person’s capacity to make a deci-
sion in the context of suicidal behaviour was discussed 
in detail.8 22 24 The capacity assessment was discussed in 
relation to when the patient was involved in advance care 
planning and making the decision to write an advance 
decision to refuse treatment.8 Capacity assessment was 
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also discussed in relation to clinicians in an emergency 
situation, treating a person who is considered to have 
capacity to verbally refuse or accept treatment. In this 
scenario the advance decision can be ignored. While this 
is an important part of some legislation, particularly in 
the UK, it was suggested that an assessment of capacity 
should be supplemented with a judgement of the authen-
ticity and durability of the patient’s decision (ie, if the 
decision had been consistent over time).22 26 Authors 
from a psychiatric perspective, in particular, suggested 
that advance decisions should be regularly reviewed to 
ensure that they were up-to-date and continued to reflect 
the patient’s desires and preferences.26–28
The length of time needed to consider all the evidence versus 
rapid decision-making for treatment
Need to fully consider the totality of evidence
Some authors suggested that the increased length of time 
taken in this particular context arose from the need to 
consider contextual factors for the suicidal behaviour,2 22 25 
the patient’s mental health background27 and the reason 
for their decision, alongside the usual validation checks and 
judgement of the presence of mental capacity at the time of 
making the advance decision. It was also argued that clini-
cians should take into account wider factors that may have 
not been present when the person first wrote the advance 
decision, such as changes in evidence for a particular treat-
ment or scientific advances offering new treatment options 
that may influence the patient’s decision.22
However, authors highlighted difficulties with gaining 
access to such evidence, particularly in emergency situa-
tions, further adding to the time taken to make a decision.31 
It was noted that advance decisions were often too specific 
(eg, related to a specific illness or injury) or too general 
(eg, a general refusal of treatment, rather than refusal of 
a specific treatment), resulting in ambiguity as to the best 
course of action for the patient and time consuming inves-
tigation.2 25 28 Some authors highlighted that advance deci-
sions were not useful in emergency settings when rapid 
decision-making was required2 but may be appropriate for 
patients to express refusals of on-going psychiatric treat-
ment (eg, electroconvulsive therapy).
Increased gravity of the clinical decision
Authors argued that the gravity of the clinical decision was 
increased in this context because the patient could die if 
the advance decision was adhered to when recovery from 
mental ill health may be possible.6 25 Authors suggested 
that validation checks in this context may need to be more 
thorough and authors from a legal perspective argued 
that, because of the increased gravity of the clinical deci-
sion, physicians should seek a consensus about clinical 
management, while providing life-sustaining treatment, 
creating a time-consuming situation.7 31
Importance of seeking support and sharing the decision
Drawing up an advance decision as a collaborative process
Some authors argued that when writing an advance decision, 
patients should be supported by a healthcare professional 
to consider all possible treatment options.2 22 23 27 29 It was 
suggested that evidence of mental capacity at the time 
of writing the advance decision should be provided (eg, 
verified and signed by the healthcare professional) which 
could help with clinical decision-making at a later stage.22 
Authors from all the perspectives stressed the importance 
of also consulting with a physician at the time of writing 
the advance decision to ensure that it is both specific and 
general enough to be helpful and informative in a given 
medical scenario.23 27
Shared decision-making
All authors discussed the need for multiagency deci-
sion-making in relation to the management of advance 
decisions in the context of suicidal behaviour.7 27 28 Sugges-
tions included that clinicians should consult widely, make 
use of psychiatric expertise, review the patient’s psychiatric 
history and background and seek legal and/or ethical 
consultation when considering treatment decisions.
DIsCussIOn
summary of the findings
A comprehensive systematic review of studies examining 
the management of advance decisions to refuse treatment 
following suicidal behaviour was conducted. The findings 
show a paucity of studies in this specific area. Fifteen 
relevant studies were identified, of which all were reports 
of clinical cases. With the exception of two papers that 
noted fictional clinical cases, the others reported on six 
real clinical cases. Despite having no language or country 
restrictions to the search, all the studies were from the 
USA, Australia or UK which have similar legislation 
relating to advance care planning and advance decisions 
to refuse treatment.2
There were inconsistent views on practice and ratio-
nales for the management of advance decisions. Treat-
ment was provided in only one clinical case, where the 
patient was a psychiatric inpatient and the advance deci-
sion was considered part of the suicide attempt.23 In this 
case the patient survived and later regretted the suicide 
attempt. In the other clinical cases, treatment was not 
provided, but rationale for non-treatment differed. Ratio-
nale for treatment varied from viewing the advance deci-
sion as legally binding8 24 to using the advance decision 
as an aide to understand the patients’ treatment pref-
erences when there was a poor prognosis or a resulting 
severely disabling condition.7 25
Conflict between clinicians was reported in some of the 
cases.23 25 In the studies where there were conflicts, there 
were differences in opinions on treatment between ED 
clinicians and psychiatrists. Consultations with mental 
healthcare staff were typically sought when a patient 
presented with an advance decision following suicidal 
behaviour. Psychiatrists tended to stress the treatable 
nature of a mental health condition and that the suicidal 
behaviour was part of the mental health disorder. In 
contrast, ED clinicians argued that the advance decision 
 o
n
 26 M
arch 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-023978 on 13 March 2019. Downloaded from 
12 Nowland R, et al. BMJ Open 2019;9:e023978. doi:10.1136/bmjopen-2018-023978
Open access 
document was legally binding and expressed anxieties 
about litigation. These differences in opinion about treat-
ment were overcome through consultations with legal 
and ethical representatives.
The appropriateness of advance decisions with suicidal 
behaviour was questioned for two reasons. First, suicide 
ideation was considered to fluctuate and people could 
change their mind about their desire to die.7 8 31 32 Although 
suicide has been linked to impulsivity,33 34 studies show that 
not all suicides are impulsive.35 However, recent studies 
using ecological momentary assessment have shown that 
suicide ideation varies over short periods of time (ie, there 
are changes between hours and days)36 and follow-up 
studies with suicide survivors tend to acknowledge that 
they regret the suicide attempt.37 Second, outcomes for 
treatment refusal following suicidal behaviour were noted 
to be potentially different to those for a terminal physical 
health condition (ie, the patient could die when there is 
potential for recovery in the future).6 32
Authors discussed concerns that management of 
advance decisions following suicidal behaviour may 
need to be different because they are a unique clinical 
presentation. Similar to findings in this review, anxieties 
and confusion about legislation relating to advance deci-
sions is also found in studies examining end-of-life care.38 
However, what differs is opinions about adherence to 
the advance decision to refuse treatment for chronic or 
terminal conditions and sympathy for assisted suicide in 
end-of-life care. Healthcare workers report support for 
assisted suicide relating to end-of-life care39 and frustra-
tions with continuing life-sustaining treatment where 
withdrawing treatment might be considered in the best 
interest of the patient when they have a life-threatening 
condition.23 40 Those findings indicate quite a contrast 
with opinions in this review where the focus was on 
management of advance decisions following suicidal 
behaviour and an expression of sympathy with the deci-
sion was not found. It will be important in future research 
to examine these differences further by contrasting views 
on management of advance decisions to refuse treatment 
following suicidal behaviour for patients with chronic 
and/or terminal physical conditions and patients without 
chronic or terminal physical conditions.
Management of the advance decision was difficult 
both emotionally and ethically for some clinicians 
because it challenged their professional training 
and their desire to protect vulnerable patients from 
suicide. The competing pressures of respecting a 
patient’s right to autonomy while protecting them 
from the effects of mental disorder found in the 
current study is a commonly reported dilemma.41 
There is evidence from the present study that support 
for the right to autonomy may be more dominant 
in clinicians from emergency medicine disciplines, 
with those from a psychiatric background prior-
itising prevention of suicide. A ‘middle ground’ 
between these views may help to provide guidance 
for clinicians. For example, in English law, courts 
have acknowledged that while some suicidal individ-
uals may have capacity, the overwhelming likelihood 
is that capacity is impaired to at least some degree.41 
Suicidal ideation has been associated with disordered 
and impulsive decision-making33 34 and evidence indi-
cates that most mental health patients presenting 
to EDs are judged as not having capacity to make a 
treatment decision.12 Therefore a higher degree of 
certainty should be required when assessing capacity 
with suicidal behaviour and clinicians should err on 
the side of caution.8 Another potential resolution to 
this dilemma, particularly in emergency scenarios, 
may be to provide ‘temporary intervention’ to allow 
time for individuals to be assessed and treatment 
options to be discussed.41
An added pressure for clinicians in the management 
of advance decisions following suicidal behaviour was 
that they felt there was a societal expectation that 
suicide should be prevented. Adhering to the advance 
decision made by the patient by not treating them, 
not only was seen to go against their professional 
training to protect the patient, but it was viewed that 
this may be considered from a society perspective as 
unacceptable. The dilemma here is that a clinical 
decision of non-treatment and adherence with the 
advance decision might be accepted legally, but not 
socially. Concerns were expressed that this particular 
presentation of an advance decision met conditions 
that warranted overriding patients’ autonomy because 
non-adherence with the advance decisions results in 
prevention of suicide, maintenance of the integrity of 
the medical professional and preservation of life.25
recommendations for practice
Decisions made about advance decisions in the context 
of suicidal behaviour should be made in full consulta-
tion with psychiatric teams and with relevant legal and/
or ethical advisers. The results also highlight the impor-
tance of allocating sufficient time to consider contextual 
evidence relating to the suicidal behaviour, the authen-
ticity of the treatment decision and verification of the 
documentation/decision. Given the gravity and emotive 
nature of a decision in this context, emergency health-
care workers may need increased support and supervision 
for such incidents.
Findings indicate that it may be helpful, in this 
particular context, for an advance decision to be 
written in consultation with a professional healthcare 
worker and the patient’s family. This practice would 
also ensure that the patient is supported to consider 
all treatment options, that the advance decision is 
specific and detailed enough to be useful in an emer-
gency situation and that patients’ capacity at the time 
of writing the advance decision can be assessed and 
verified. The advance decision should be regularly 
reviewed and updated to ensure that it reflects the 
patient’s current treatment decisions.
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strengths and limitations
A strength of this review is that a broad range of arti-
cles from different disciplines were included, thus 
increasing the generalisability of results. However, 
there were some potential biases in the literature. 
First, there was a paucity of evidence: only six clinical 
cases were reported across the selected articles. There 
was also a risk of bias from the studies themselves, 
given that they were reviews of single clinical cases. 
Second, the articles were focused on the USA, UK 
and Australia, so may have resulted in bias relating 
to the specific legislation/ethics of those countries. 
There may be different views on this topic and its 
management in countries with different implementa-
tion of legislation, so it will be important for future 
research to compare findings internationally across 
a wider range of countries.42–44 Third, as with any 
syntheses of qualitative data there was potential for 
bias to be introduced by the research team at the 
stages of study identification, data extraction and 
synthesis. This was minimised in the current study 
by having two researchers carry out these tasks inde-
pendently and cross-check the findings.
Future directions
Empirical studies, such as interviews and focus groups 
with clinicians and patients and/or a national clinical 
survey are important future priorities. Given that the 
presentation of an advance decision following suicidal 
behaviour is rare, case reports are likely to continue 
to be important sources of information in the future 
and authors should be mindful to ensure that case 
reports include details about how information about 
the case were obtained and how representative it is 
of other cases in this area. Research examining the 
prevalence of advance decisions relating to suicidal 
behaviour could shed light on the frequency of such 
presentations. Suitable platforms for storing advance 
decisions could also be explored. For example, some 
have suggested a web application (‘app’) could better 
reflect the dynamic nature of treatment refusal45 and 
make updating and reassessment easier.
COnClusIOn
Current literature on the management of advance 
decisions and suicidal behaviour centres on detailed 
accounts of clinical cases and demonstrates vari-
ability in practice and the rationale behind clinical 
decisions. Challenges in managing advance decisions 
specific to suicidal behaviour were evident, and there 
was some debate about whether advance decisions in 
the context of suicidal behaviour were appropriate 
in their current form. Taking time to consider all the 
evidence when making a decision, consulting fully 
with mental health clinicians and seeking legal and/or 
ethical advice may help with some of these challenges. 
The support of a relevant healthcare professional at 
the time of writing the advance decision may also be 
useful.
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